The recommended dose for moderate pain is 1 hard capsule (corresponding to 50 mg of tramadol hydrochloride). If pain relief is not achieved in 30 to 60 minutes, a second capsule can be taken.
To relieve severe painyou can expect a greater analgesic demand, in this case, 2 hard capsules can be taken at the same time as a single dose (corresponding to 100 mg of tramadol hydrochloride).
Use in children
This medicationis not recommended for children under 12 years old.
Older patients
In elderly patients (over 75 years old), the elimination of tramadol may be slow. If this is your case, your doctor may recommend prolonging the dosing intervals.
Patients with severe liver or kidney failure and patients on dialysis:
If you have severe liver or kidney failure, treatment with tramadol is not recommended. If your liver or kidney failure is mild or moderate, your doctor may prolong the dosing intervals.
How and when to take Tramadol Krka?
The capsules are administered orally.
You should swallow the capsules whole without dividing or chewing them and with sufficient liquid.
You can take this medication both with an empty stomach and with meals.
For how long should you take Tramadol Krka?
This medication should not be administered for longer than strictly necessary. If you require prolonged treatment, your doctor will monitor you at short and regular intervals (if necessary with interruptions in treatment) to see if you should continue treatment with tramadol and at what dose.
If you estimate that the effect of this medication is too strong or too weak, inform your doctor or pharmacist.
If you take more Tramadol Krka than you should
If you have taken an additional dose of tramadol by mistake, this usually has no negative effects. You should take the next dose as prescribed.
If you (or someone else) ingest many capsules of this medication at the same time, you should go to the hospital or call a doctor immediately. Signs of overdose include very small pupils, vomiting, decreased blood pressure, rapid heart rate, circulatory collapse, unconsciousness to coma (deep unconsciousness), seizures, and respiratory difficulties or shallow breathing to respiratory arrest. If these symptoms appear, contact your doctor immediately.
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount taken. It is recommended to bring the medication leaflet to the healthcare professional.
If you forget to take Tramadol Krka
If you forget to take tramadol, it is likely that the pain will return. Do not take a double dose to compensate for the missed doses, simply continue taking this medication as you have been doing until now.
If you interrupt treatment with Tramadol Krka
If you interrupt or discontinue treatment with tramadol too soon, it is likely that the pain will return.
If you want to interrupt treatment due to side effects, consult your doctor.
You should not suddenly stop taking this medication unless your doctor tells you to. If you want to stop taking your medication, talk to your doctor first, especially if you have been taking it for a long time. Your doctor will advise you when and how to discontinue it, which can be done by gradually reducing the dose to reduce the possibility of unnecessary side effects (withdrawal symptoms).
Generally, no adverse effects occur when treatment is interrupted with this medication. However, in rare cases, people who have been taking tramadol for some time may not feel well when treatment is stopped abruptly. They may feel agitated, anxious, nervous, or have tremors. They may be hyperactive, have difficulty sleeping, or experience gastrointestinal and intestinal transit problems. Very few people experience panic attacks, hallucinations, unusual perceptions such as itching, numbness, tingling, and ringing in the ears (tinnitus). Very rarely, more unusual symptoms of the central nervous system have been detected, such as confusion, delirium, change in perception of one's own personality (derealization), and change in perception of reality (depersonalization) and delusions of persecution (paranoia). If you experience any of these symptoms after stopping treatment with this medication, consult your doctor or pharmacist.
4. Possible Adverse Effects
Like all medicines, this medicine may cause side effects, although not everyone will experience them.
You should consult a doctor immediately if you experience symptoms of an allergic reaction, such as swelling of the face, tongue, and/or throat, and/or difficulty swallowing, or hives along with difficulty breathing.
Very common(may affect more than 1 in 10 people)
Dizziness
Nausea
Common(may affect up to 1 in 10 people)
Headache and numbness
Fatigue
Vomiting, constipation, and dry mouth
Excessive sweating (hyperhidrosis)
Uncommon(may affect up to 1 in 100 people)
Effects on the heart and blood circulation (strong heartbeats and rapid heartbeats (tachycardia), feeling of dizziness (orthostatic hypotension or circulatory collapse). These side effects may occur particularly in patients who are lying down or who are engaging in physical activity.
Desire to vomit (retching), gastrointestinal discomfort (e.g. feeling of pressure in the stomach, heaviness), diarrhea
Skin reactions (e.g. itching, skin rash)
Rare(may affect up to 1 in 1,000 people)
Allergic reactions (e.g. difficulty breathing (dyspnea), wheezing, fluid retention in tissues (angioedema) and shock (sudden circulatory failure) have occurred in very rare cases
Slow heart rate (bradycardia)
Increased blood pressure
Abnormal skin sensations (e.g. itching, tingling, numbness), tremors, involuntary muscle contractions, uncoordinated movements, transient loss of consciousness (syncope), speech disorders
Seizures occur mainly after taking high doses of tramadol or when another medication that may induce them is taken simultaneously.
Changes in appetite
Hallucinations, confusion, sleep disturbances, delirium, anxiety, and nightmares
Psychological changes may occur after treatment with tramadol. Their intensity and nature may vary (depending on the patient's personality and the duration of treatment). These may appear in the form of mood changes (usually euphoria, occasionally irritability), changes in activity (usually decreased and occasionally increased) and decreased cognitive and sensory perception (being less aware and less capable of decision-making, which may lead to judgment errors).
It may cause drug dependence
When treatment is stopped abruptly, withdrawal syndrome (see "If you stop taking Tramadol Krka") may occur.
Blurred vision, excessive dilation of the pupils (mydriasis), constriction of the pupils (miosis)
Slow breathing (respiratory depression), lack of air (dyspnea)
There have been reports of cases of worsening asthma, however it has not been established whether they were caused by tramadol. Exceeding the recommended doses or taking it simultaneously with other medications that depress brain function may cause a decrease in respiratory frequency.
Muscle weakness
Difficulty or pain urinating, less urine than normal (urinary disorders and dysuria)
Very rare(may affect up to 1 in 10,000 people)
Increased liver enzymes
Frequency not known(frequency that cannot be estimated from available data)
Decreased blood sugar level
Hypophagia
Serotonin syndrome, which may manifest as changes in mental state (e.g. agitation, hallucinations, coma), and other effects, such as fever, increased heart rate, unstable blood pressure, involuntary muscle contractions, muscle rigidity, lack of coordination, and/or gastrointestinal symptoms (e.g. nausea, vomiting, diarrhea) (see section 2 "What you need to know before taking Tramadol Krka").
Reporting of adverse reactions:
If you experience any type of adverse reaction, consult your doctor or pharmacist, even if it is a possible adverse reaction that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting adverse reactions, you can contribute to providing more information on the safety of this medicine.
5. Conservation of Tramadol Krka
Keep this medication out of the sight and reach of children.
Store this medication in a safe and protected place, to which other people cannot access. This medication can cause serious harm or even be fatal to individuals who have not been prescribed it.
Do not use this medication after the expiration date that appears on the packaging after “CAD”. The expiration date is the last day of the month indicated.
Do not store above 30°C.
Store in the original packaging to protect it from moisture.
Medications should not be disposed of through drains or in the trash. Deposit the packaging and medications you no longer need at the SIGRE collection point at the pharmacy. Ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
6. Contents of the packaging and additional information
Composition of Tramadol Krka
The active ingredient is tramadol hydrochloride. Each hard capsule contains 50 mg of tramadol hydrochloride.
The other components are: microcrystalline cellulose, sodium carboxymethyl starch (type A), talc, magnesium stearate (E470b) in the capsule core and titanium dioxide (E171), indigo carmine (E132) and gelatin in the capsule coating.
Appearance of Tramadol Krkaand contents of the package:
Hard capsules (capsules): the capsule body is white and the cap is blue. Capsules containing a white or almost white powder. Capsule size No. 4. Capsule length 14-15 mm.
It is presented in packages containing 10, 20, 30, 50, 60, 90, and 100 hard capsules in blisters.
Only some package sizes may be marketed.
Marketing Authorization Holder
KRKA, d.d., Novo mesto
Šmarješka cesta 6
8501 Novo mesto
Slovenia
Responsible for manufacturing
KRKA, d.d., Novo mesto
Šmarješka cesta 6
8501 Novo mesto
Slovenia
You can request more information about this medication by contacting the local representative of the marketing authorization holder:
KRKA Farmacéutica, S.L.
Calle de Anabel Segura 10
28108 Alcobendas, Madrid
Spain
This medication is authorized in the member states of the European Economic Area with the following names:
Member state
Name
Croatia
Awardix 50 mg hard capsules
Belgium
Tramadol Krka 50 mg
Bulgaria
???????? ????50 mg???????, ??????
Czech Republic
Tramadol Krka
Denmark
Tramadol Krka
Hungary
Tramadol Krka 50 mg hard capsule
Ireland
Tramadol Krka 50 mg capsule, hard
Italy
Tramadolo Krka
Spain
Tramadol Krka 50 mg hard capsules EFG
Poland
Tramadol Krka
Portugal
Tramadol Krka 50 mg capsules
Sweden
Tramadol Krka 50 mgkapslar, hårda
Slovakia
Tramadol Krka 50 mgtvrdé kapsuly
United Kingdom
Tramadol Krka 50 mg capsule, hard
Last review date of thisleaflet: July 2024
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/).
Информация носит справочный характер и не является медицинской рекомендацией. Перед приёмом любых препаратов проконсультируйтесь с врачом. Oladoctor не несёт ответственности за медицинские решения, принятые на основе этого контента.
Общайтесь с врачом онлайн
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.